{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T21:19:17Z","timestamp":1787606357204,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-026-05199-5","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T07:44:18Z","timestamp":1787557458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sympathetic ophthalmia complicating proliferative diabetic retinopathy: diagnostic and therapeutic challenges during pregnancy"],"prefix":"10.1186","volume":"26","author":[{"given":"Norah","family":"Alshabib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motazz","family":"Alarfaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Albahlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora A.","family":"Alyousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"5199_CR1","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1177\/1120672120977359","volume":"31","author":"J Yang","year":"2021","unstructured":"Yang J, Li Y, Xie R, Li X, Zhang X. Sympathetic ophthalmia: report of a case series and comprehensive review of the literature. Eur J Ophthalmol. 2021;31:3099\u2013109.","journal-title":"Eur J Ophthalmol"},{"key":"5199_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0039-6257(79)90018-3","volume":"24","author":"GE Marak Jr","year":"1979","unstructured":"Marak GE Jr. Recent advances in sympathetic ophthalmia. Surv Ophthalmol. 1979;24:141\u201356.","journal-title":"Surv Ophthalmol"},{"key":"5199_CR3","doi-asserted-by":"publisher","first-page":"100816","DOI":"10.1016\/j.ajoc.2020.100816","volume":"19","author":"AM Williams","year":"2020","unstructured":"Williams AM, Shepler AM, Chu CT, Nischal KK. Sympathetic ophthalmia presenting 5 days after penetrating injury. Am J Ophthalmol Case Rep. 2020;19:100816.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"5199_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12886-024-03410-z","volume":"24","author":"H Li","year":"2024","unstructured":"Li H, Li Z, Mao A, Dong P, Wang W. A case report: co-occurrence of probable Vogt-Koyanagi-Harada disease and diabetic retinopathy. BMC Ophthalmol. 2024;24:148.","journal-title":"BMC Ophthalmol"},{"key":"5199_CR5","doi-asserted-by":"publisher","first-page":"100511","DOI":"10.1016\/j.xops.2024.100511","volume":"4","author":"A Mohapatra","year":"2024","unstructured":"Mohapatra A, Sudharshan S, Majumder PD, Sreenivasan J, Raman R. Clinical profile and ocular morbidities in patients with both diabetic retinopathy and uveitis. Ophthalmol Sci. 2024;4:100511.","journal-title":"Ophthalmol Sci"},{"key":"5199_CR6","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/sj.eye.6702927","volume":"22","author":"V Gupta","year":"2008","unstructured":"Gupta V, Gupta A, Dogra MR. Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India. Eye (Lond). 2008;22:1459\u201364.","journal-title":"Eye (Lond)"},{"key":"5199_CR7","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.4103\/ijo.IJO_2363_21","volume":"70","author":"S Parchand","year":"2022","unstructured":"Parchand S, Agrawal D, Ayyadurai N, Agarwal A, Gangwe A, Behera S, et al. Sympathetic ophthalmia: a comprehensive update. Indian J Ophthalmol. 2022;70:1931\u201344.","journal-title":"Indian J Ophthalmol"},{"key":"5199_CR8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ophtha.2012.01.043","volume":"119","author":"JD Udoetuk","year":"2012","unstructured":"Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, et al. Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology. 2012;119:1569\u201374.","journal-title":"Ophthalmology"},{"key":"5199_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000055677","volume":"33","author":"M Santos Lacomba","year":"2001","unstructured":"Santos Lacomba M, Marcos Martin C, Gallardo Galera JM, Gomez Vidal MA, Collantes Estevez E, Ramirez Chamond R, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33:251\u20135.","journal-title":"Ophthalmic Res"},{"key":"5199_CR10","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1001\/jamaophthalmol.2014.426","volume":"132","author":"JB Kim","year":"2014","unstructured":"Kim JB, Jeroudi A, Angeles-Han ST, Grossniklaus HE, Yeh S. Adalimumab for pediatric sympathetic ophthalmia. JAMA Ophthalmol. 2014;132:1022\u20134.","journal-title":"JAMA Ophthalmol"},{"key":"5199_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajoc.2019.01.009","volume":"14","author":"T Hiyama","year":"2019","unstructured":"Hiyama T, Harada Y, Kiuchi Y. Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab. Am J Ophthalmol Case Rep. 2019;14:1\u20134.","journal-title":"Am J Ophthalmol Case Rep"},{"key":"5199_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jcrs.2012.02.026","volume":"38","author":"M Soheilian","year":"2012","unstructured":"Soheilian M, Jabbarpour Bonyadi M, Soheilian R, Peyman GA. Bilateral uveitis after phakic intraocular lens implantation and management with adalimumab. J Cataract Refract Surg. 2012;38:1094\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"5199_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","volume":"375","author":"GJ Jaffe","year":"2016","unstructured":"Jaffe GJ, Dick AD, Br\u00e9zin AP, Nguyen QD, Thorne JE, Kestelyn P, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932\u201343.","journal-title":"N Engl J Med"},{"key":"5199_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","volume":"388","author":"QD Nguyen","year":"2016","unstructured":"Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388:1183\u201392.","journal-title":"Lancet"},{"key":"5199_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12348-025-00529-y","volume":"15","author":"CA Rodr\u00edguez-Fern\u00e1ndez","year":"2025","unstructured":"Rodr\u00edguez-Fern\u00e1ndez CA, Rodriguez-Mart\u00ednez L, Rodr\u00edguez Lemos O, de Domingo B, Garc\u00eda Bru P, Gestoso A, et al. Adalimumab in non-infectious uveitis, towards a real-world therapeutic paradigm beyond inflammation control: a multicenter cross-sectional study. J Ophthalmic Inflamm Infect. 2025;15:76.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"5199_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/bjophthalmol-2013-303358","volume":"97","author":"NPY Chiam","year":"2013","unstructured":"Chiam NPY, Hall AJH, Stawell RJ, Busija L, Lim LLP. The course of uveitis in pregnancy and postpartum. Br J Ophthalmol. 2013;97:1284\u20138.","journal-title":"Br J Ophthalmol"},{"key":"5199_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/ph16101433","volume":"16","author":"G Demarinis","year":"2023","unstructured":"Demarinis G, Tatti F, Taloni A, Giugliano AV, Panthagani J, Myerscough J, et al. Treatments for ocular diseases in pregnancy and breastfeeding: a narrative review. Pharmaceuticals (Basel). 2023;16:1433.","journal-title":"Pharmaceuticals (Basel)"},{"key":"5199_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/diacare.23.8.1084","volume":"23","author":"Diabetes Control and Complications Trial Research Group","year":"2000","unstructured":"Diabetes Control and Complications Trial Research Group. Effect of pregnancy on microvascular complications in the Diabetes Control and Complications Trial. Diabetes Care. 2000;23:1084\u201391.","journal-title":"Diabetes Care"},{"key":"5199_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jamaophthalmol.2022.0050","volume":"140","author":"F Widyaputri","year":"2022","unstructured":"Widyaputri F, Rogers SL, Kandasamy R, Shub A, Symons RCA, Lim LL. Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes: a systematic review and meta-analysis. JAMA Ophthalmol. 2022;140:486\u201394.","journal-title":"JAMA Ophthalmol"},{"key":"5199_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2005.09.005","volume":"141","author":"JA Knol","year":"2006","unstructured":"Knol JA, van Kooij B, de Valk HW, Rothova A. Rapid progression of diabetic retinopathy in eyes with posterior uveitis. Am J Ophthalmol. 2006;141:409\u201312.","journal-title":"Am J Ophthalmol"},{"key":"5199_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.21037\/aes.2018.09.04","volume":"3","author":"M De Maria","year":"2018","unstructured":"De Maria M, Panchal B, Coassin M. Update on indications for diabetic vitrectomy and management of complications. Ann Eye Sci. 2018;3:51.","journal-title":"Ann Eye Sci"},{"key":"5199_CR22","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00417-022-05862-9","volume":"261","author":"JH Hung","year":"2023","unstructured":"Hung JH, Rao NA, Chiu WC, Sheu SJ. Vitreoretinal surgery in the management of infectious and non-infectious uveitis - a narrative review. Graefes Arch Clin Exp Ophthalmol. 2023;261:913\u201323.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5199_CR23","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1007\/s00417-024-06407-y","volume":"262","author":"H Celiker","year":"2024","unstructured":"Celiker H, \u00c7am F, \u00d6zko\u00e7ak BY. Outcomes of pars plana vitrectomy in the management and diagnosis of patients with infectious, non-infectious, and unidentified uveitis. Graefes Arch Clin Exp Ophthalmol. 2024;262:2237\u201346.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"5199_CR24","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","volume":"62","author":"MD Russell","year":"2023","unstructured":"Russell MD, Dey M, Flint J, Davie P, Allen A, Crossley A, et al. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology (Oxford). 2023;62(4):e48\u201388.","journal-title":"Rheumatology (Oxford)"},{"key":"5199_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41433-023-02811-6","volume":"38","author":"AY Ong","year":"2024","unstructured":"Ong AY, Kiire CA, Frise C, Bakr Y, de Silva SR. Intravitreal anti-vascular endothelial growth factor injections in pregnancy and breastfeeding: a case series and systematic review of the literature. Eye (Lond). 2024;38:951\u201363.","journal-title":"Eye (Lond)"},{"issue":"12","key":"5199_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","volume":"98","author":"RL Avery","year":"2014","unstructured":"Avery RL, Castellarin AA, Steinle NC, Dhoot DS, Pieramici DJ, See R, et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD. Br J Ophthalmol. 2014;98(12):1636\u201341.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05199-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05199-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:27:32Z","timestamp":1787603252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05199-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5199"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05199-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Institutional Review Board approval was obtained at our hospital, King Khaled Eye Specialist Hospital and Research Center, in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case and accompanying images.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"514"}}